Christopher Murriel

Principal Scientific Advisor, Discovery Oncology
San Francisco, CA

Christopher Murriel is a Principal Scientific Advisor within Discovery Oncology with extensive experience and expertise in oncology drug discovery.  Prior to Charles River, Dr. Murriel was an Associate Director in the Department of Research at OncoMed Pharmaceuticals where he directed preclinical study efforts aimed at determining the efficacy, MoA, and pharmacodynamic effects of OncoMed’s pipeline of small molecule and biologic research and development programs involving cancer stem cell, anti-agiogenic, immuno-oncology, and autoimmune diseases. In addition, Chris has diverse expertise in developing cancer mouse models including PDX, syngeneic, genetically engineered, humanized, as well as those involved in autoimmune disease research.